Greenleaf Trust bought a new stake in Everest Re Group, Ltd. (NYSE:RE) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,789 shares of the insurance provider’s stock, valued at approximately $455,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. RMB Capital Management LLC purchased a new position in shares of Everest Re Group during the fourth quarter worth about $1,434,000. UBS Asset Management Americas Inc. boosted its position in shares of Everest Re Group by 3.1% in the fourth quarter. UBS Asset Management Americas Inc. now owns 349,694 shares of the insurance provider’s stock worth $75,674,000 after buying an additional 10,627 shares during the period. Raymond James Trust N.A. boosted its position in shares of Everest Re Group by 1.7% in the first quarter. Raymond James Trust N.A. now owns 17,972 shares of the insurance provider’s stock worth $4,202,000 after buying an additional 294 shares during the period. Bank of Montreal Can boosted its position in shares of Everest Re Group by 3.4% in the first quarter. Bank of Montreal Can now owns 234,699 shares of the insurance provider’s stock worth $54,876,000 after buying an additional 7,775 shares during the period. Finally, Regentatlantic Capital LLC boosted its position in shares of Everest Re Group by 1.5% in the first quarter. Regentatlantic Capital LLC now owns 10,783 shares of the insurance provider’s stock worth $2,521,000 after buying an additional 160 shares during the period. 92.69% of the stock is currently owned by institutional investors.

Everest Re Group, Ltd. (RE) opened at 265.67 on Monday. The stock’s 50 day moving average is $260.59 and its 200-day moving average is $243.04. Everest Re Group, Ltd. has a one year low of $183.04 and a one year high of $277.17. The firm has a market cap of $10.91 billion, a price-to-earnings ratio of 9.10 and a beta of 0.63.

Everest Re Group (NYSE:RE) last released its quarterly earnings results on Monday, July 24th. The insurance provider reported $5.51 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $5.24 by $0.27. The business had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.46 billion. Everest Re Group had a net margin of 19.65% and a return on equity of 13.60%. During the same period in the prior year, the firm posted $3.17 earnings per share. On average, equities research analysts expect that Everest Re Group, Ltd. will post $21.29 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “1,789 Shares in Everest Re Group, Ltd. (NYSE:RE) Acquired by Greenleaf Trust” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2017/08/07/greenleaf-trust-buys-shares-of-1789-everest-re-group-ltd-nysere-updated.html.

RE has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods cut shares of Everest Re Group from a “market perform” rating to an “underperform” rating and decreased their price objective for the company from $251.00 to $245.00 in a research note on Monday, July 17th. Deutsche Bank AG restated a “buy” rating and issued a $262.00 target price (up previously from $240.00) on shares of Everest Re Group in a research report on Saturday, April 29th. Zacks Investment Research upgraded shares of Everest Re Group from a “hold” rating to a “buy” rating and set a $293.00 target price on the stock in a research report on Friday, July 7th. Morgan Stanley restated an “equal weight” rating and issued a $259.00 target price (up previously from $250.00) on shares of Everest Re Group in a research report on Thursday, July 6th. Finally, Wells Fargo & Company restated a “hold” rating on shares of Everest Re Group in a research report on Monday, April 24th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company’s stock. Everest Re Group currently has an average rating of “Hold” and a consensus target price of $249.50.

Everest Re Group Company Profile

Everest Re Group, Ltd., through its subsidiaries, is engaged in the underwriting of reinsurance and insurance in the United States, Bermuda and international markets. The Company operates in segments: U.S. Reinsurance, International, Bermuda and Insurance segment. The Company underwrites reinsurance both through brokers and directly with ceding companies.

Institutional Ownership by Quarter for Everest Re Group (NYSE:RE)

Receive News & Stock Ratings for Everest Re Group Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everest Re Group Ltd. and related stocks with our FREE daily email newsletter.